Enzyme Responsive Magnetic Nanoparticles for Targeted Drug Delivery and Precision Medicine
Drug Development Research · 2025-11 · 86 (7)
DOI: 10.1002/ddr.70185 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 10.11.2025. Verfasst von Zhenchen Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: China Three Gorges University, Yichang City, Hubei Province, China. Hauptthemen laut MEDLINE: Precision Medicine, Drug Delivery Systems, Magnetite Nanoparticles, Enzymes. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 177 Literaturangaben.
Abstract (Originalsprache)
Enzyme‐responsive magnetic nanoparticles (MNPs) represent an emerging class of multifunctional drug delivery systems that combine spatial precision with biochemical selectivity. By integrating magnetic guidance with enzyme‐triggered activation, these nanocarriers address a critical limitation of conventional chemotherapy, namely the lack of specificity that often leads to systemic toxicity and reduced therapeutic efficacy. Enzymes such as proteases, phospholipases, and oxidoreductases are frequently dysregulated in pathological tissues, providing endogenous signals that can be harnessed for site‐specific drug release. Enzyme‐responsive MNPs exploit these biochemical signatures by incorporating cleavable linkers, enzyme‐sensitive coatings, or catalytic cascades, ensuring that therapeutic payloads are released selectively in tumor microenvironments, inflamed regions, or infection sites. Advances in nanoparticle synthesis have further enabled fine‐tuning of magnetic cores, polymer shells, and functionalized surfaces, thereby enhancing stability, drug loading capacity, and responsiveness. Preclinical studies demonstrate substantial benefits, including enhanced tumor accumulation, alleviation of hypoxia, improved drug penetration through stromal barriers, and reduction of off‐target toxicity. Applications extend beyond oncology to infectious diseases, where pathogen‐derived enzymes activate antibiotic release, and to metabolic disorders, where glucose oxidase‐based systems regulate insulin delivery. Despite these promising outcomes, translation to clinical practice is constrained by manufacturing challenges, variable enzyme expression, limited in vivo data, and stringent regulatory requirements. This review critically examines the principles, design strategies, release mechanisms, and biomedical applications of enzyme‐responsive MNPs, while highlighting unresolved barriers and future directions. Ultimately, enzyme‐responsive MNPs exemplify the potential of precision nanomedicine, offering a platform for highly adaptable, multimodal, and patient‐tailored therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- China Three Gorges University, Yichang City, Hubei Province, China.
- Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Chemical and Electrochemical Processing Department, Central Metallurgical Research and Development Institute (CMRDI), Helwan, Egypt.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
- Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, India.
- Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, India.
ORCID-Profile: Ebraheem Abdu Musad Saleh, Abhayveer Singh, A Sabarivani, Samir Sahoo, Chou-Yi Hsu
Zitieren
APA
Du, Z., Saleh, E. A. M., M Moharam, M., Rab, S. O., Ballal, S., Singh, A., Sabarivani, A., Sahoo, S., & Hsu, C. Y. (2025). Enzyme Responsive Magnetic Nanoparticles for Targeted Drug Delivery and Precision Medicine. Drug Development Research, 86(7). https://doi.org/10.1002/ddr.70185
Vancouver
Du Z, Saleh EAM, M Moharam M, Rab SO, Ballal S, Singh A, et al. Enzyme Responsive Magnetic Nanoparticles for Targeted Drug Delivery and Precision Medicine. Drug Development Research. 2025;86(7). doi:10.1002/ddr.70185
BibTeX
@article{Du2025,
author = {Du, Zhenchen and Saleh, Ebraheem Abdu Musad and M Moharam, M and Rab, Safia Obaidur and Ballal, Suhas and Singh, Abhayveer and Sabarivani, A and Sahoo, Samir and Hsu, Chou-Yi},
title = {Enzyme Responsive Magnetic Nanoparticles for Targeted Drug Delivery and Precision Medicine},
journal = {Drug Development Research},
year = {2025},
volume = {86},
number = {7},
doi = {10.1002/ddr.70185}
}
EUVIMED